2 mg of retatrutide is 20 units at the common 10 mg/mL concentration, or 40 units at 5 mg/mL
Standard reconstitution produces injectable solution
One burns what's there, the other changes the trajectory, burning fat instead of storing it
Common Side Effects When side effects occurred, they were typically mild, transient, and similar in frequency to placebo groups: Reported Adverse Effects Most Common (occurring in small percentage of participants): Mild to moderate headaches (most frequently reported, often resolving with continued use) Injection site reactions (minor redness, swelling, or irritation at injection site) Gastrointestinal effects (particularly at higher oral doses: mild nausea, diarrhea, flatulence) Fatigue (reported occasionally during initial adaptation period) Rare Events: One case of chest tightness was deemed possibly related to treatment in safety trials
This is standard technique for sealed vials and should be done routinely, not just when you encounter resistance
Low-intensity aerobic work at this intensity preferentially burns fatty acids over glucose, which theoretically aligns with the liberated free fatty acids from AOD-9604 stimulation
